Approved Study Database

Ref. No. Scientific Title Principal investigator
2014.360 Burden, distress and quality of life and moderating effects of mental flexibility and personality traits in caregivers of patients with Frontotemporal Lobar Degeneration Prof. MOK Vincent Chung Tong
2016.666 A Review Of Myotonic Dystrophy In Hong Kong Prof. MOK Vincent Chung Tong
莫仲棠
2016.099 Enhanced External Counterpulsation for Cerebral Confluent White Matter Hyperintensities Prof. MOK Vincent Chung Tong
莫仲棠
2013.025 Cilostazol and Cerebral Haemodynamics in Cerebral Small Vessel Disease Prof. Mok Vincent Chung Tong
2009.032 Neuroimaging Predictors for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion Prof Mok Vincent Chung Tong
2011.238 Comparative assessment of difference in reward processing of the brain among normal subjects, stroke patients and major depressive disorder patients Prof. MOK Vincent Chung Tong
2010.540 Transcranial Doppler Ultrasound for Detection of Cerebral White Matter Changes in High-Risk Population Prof Mok Vincent Chung Tong
2013.433 Development of normative data for NINDS - Canadian Stroke Network Vascular Cognitive Impairment Neuropsychology Protocols Prof. MOK Vincent Chung Tong
2009.495 Early Identificaion of significant subclinical brain lesions in community-dwelling elderly persons in Hong Kong Prof Mok Vincent Chung Tong
2009.530 Efficacy of Rivastigmine Transdermal Patch in Dementia Patients who do not benefit from Oral Acetylcholinesterase Inhibitors (AChIs) Prof Mok Vincent Chung Tong
2011.406 Adaptation of the Booklet Category Test in Chinese: A pilot study Prof MOK Vincent Chung Tong
2011.090 Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong Prof. MOK Vincent Chung Tong
2014.023 Hong Kong Registry of Early Onset Dementia Prof. MOK Vincent Chung Tong
2008.240 A Pilot Study Using Pittsburg Compound-B Positron Emission Tomography in the Evalulation of Poststroke Dementia Prof Mok Vincent Chung Tong
2022.374 Quantitative Neuroimaging Index for Early Detection of Dementia Prof. MOK Vincent Chung Tong
莫仲棠
2011.533 Statins and White Matter Lesion Progression: A Randomized, Open-Label, Parallel-Group Study Prof. Mok Vincent Chung Tong
2013.680 Cilostazol in Decreasing progression of cerebral white matter hyperintensities (DREAM) Prof. MOK Vincent Chung Tong
2011.611 Phase II of Pilot Study of Cognitive Registry at Acute Stroke Unit at Prince of Wales Hospital Prof. MOK Vincent Chung Tong
2012.552 Regression Of Cerebral Arteriosclerotic white matter lesion progression using Statins (ROCAS 2) study Prof Mok Vincent Chung Tong
2020.374 Longitudinal follow up study of patients with Alzheimer’s disease using advanced multiparametric MR imaging Prof. MOK Vincent Chung Tong
莫仲棠
2019.147 Imaging, clinical and other biomakers of small vessel disease (ICOS) Prof. MOK Vincent Chung Tong
莫仲棠
2020.194 Effectiveness of oculomotor training on dynamic vision and functional performance in Parkinson’s disease – A randomized clinical trial Prof. MOK Vincent Chung Tong
莫仲棠
2019.350 Comprehensive Analysis Of Molecular, Structural And Functional Biomarkers For Alzheimer's Disease In The Chinese Population (UAD) Prof. MOK Vincent Chung Tong
莫仲棠
2019.391 Transcranial Pulse Stimulation (TPS) for Neurological diseases Pilot study Prof. MOK Vincent Chung Tong
莫仲棠
2018.615 Follow-up study of a cuffless blood pressure monitoring device for dementia evaluation (Phase II) Prof. MOK Vincent Chung Tong
莫仲棠
2018.334 A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE III STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER’S DISEASE Prof. MOK Vincent Chung Tong
莫仲棠
2020.620 A Phase 3, multi-center, randomized, double-blind, parallel-group, placebo-controlled clinical trial to evaluate the efficacy and safety of sodium oligomannate (GV-971) in treatment of mild to moderate Alzheimer’s disease (GREEN MEMORY: GREen Valley 971 EvaluatioN Memory) Prof. MOK Vincent Chung Tong
莫仲棠
2008.083 Comparison and Characterisation of LRRK2 Mutations and Phenotypic Features Between Northern and Southern Chinese Parkinson's Disease Patients Prof Mok Vincent, Chung Tong
2015.303 Factors determining the uptake of influenza vaccine among children with chronic medical conditions Ms. MOK Yin Ki
莫燕琪
2024.041 Effects of Dyadic Motivational Interviewing (MI-Dyad) Program for Improving Activity Participation of Stroke Survivors and Family Caregivers: A Mixed-Methods Feasibility Study Ms. MOU Huanyu
牟焕玉
2020.489 Effectiveness of family-focused dyadic psychoeducational intervention (FDPEI) for stroke survivors and family caregivers on functional and psychosocial well-being: A randomised controlled trial Ms. MOU Huanyu
2020.335 20-Year Review of Abdominal Neuroblastoma in a Tertiary Centre Dr. MOU Jennifer Wai Cheung
2016.424 How Diet Affect the Growth in Infants with Biliary Atresia: Breastfeed versus Artificial Formula Feed Dr. MOU Jennifer Wai Cheung
2013.491 Assessing impact of CYP2B6-G516T polymorphisms on plasma efavirenz levels in Chinese HIV-positive patients using a pharmacokinetic model. Is there scope to individualise patient therapy? Dr Naftalin Claire
2017.338 The Validation and Applicability of the Chinese Version of the Patient Dignity Inventory in a Hong Kong Palliative Care Setting Dr. NATARAJAN Deepa
2019.081 Acceptance and commitment therapy for managing psychological distress and improving quality of life in patients with advanced cancer: a pilot one group pretest-posttest study Dr. NATARAJAN Deepa
2019.539 Eating-related distress and depression in advanced cancer patients with anorexia-cachexia symptoms: A cross-sectional survey Dr. NATARAJAN Deepa
2018.088 Price of vaccines not in Hong Kong's Childhood Immunisation Programme: effect on financing models and cost-effectiveness Prof. NELSON E. Anthony S.
2018.095 Assessing the Perceived Benefits of Establishing a Vaccine Pooled Procurement Mechanism for the Western Pacific Region Prof. NELSON E. Anthony S.
2008.239 Pilot Hong Kong Framework for Immunisation Monitoring and Surveillance Prof. NELSON E.A.S.
2011.394 An analysis of the seasonal and pandemic influenza disease burden and clinical spectrum of illness (including severe infections requiring intensive care) associated with influenza infection in infants less than 6 months of age in Hong Kong for considerati Prof Nelson EAS
2019.083 Hong Kong Growth Study – Phase 1 Prof. NELSON Edmond Anthony
2007.475 A Pilot Non-Inferiority Immunogenicity Single Blind Randomised Study of Two Human Papillomavirus Vaccines Administered Intradermally to Females Aged 10 to 15 Years, 18 to 26 Years and 36 to 45 Years to Bridge Previous Efficacy Findings of Intramuscularly Administered Vaccine Prof Nelson Edmund
2007.479 Economic Evaluation of Routine Childhood Influenza Vaccine in Hong Kong Prof Nelson Edmund
2012.507 Dose-ranging study of safety, reactogenicity and immunogenicity of a human papillomavirus vaccine administered intradermally and intramuscularly to adults aged 20 to 26 years Prof Nelson Edmund A S
2010.596 Phase 1 Randomised study to assess immunogenicity, reactogenecity, safety and tolerability of two pneumococcal conjugate vaccines administered intraderamlly and intramuscularly to adults aged 20 to 50 years Prof NELSON Edmund A.S.
2014.156 Development of system using routine surveillance data to estimate influenza vaccine effectiveness for hospitalised Hong Kong children Prof. NELSON Edmund Anthony
2011.619 Lifestyle intervention using an internet-based curriculum with cell phone reminders among obese Chinese adolescents: A randomized controlled pilot study Professor Nelson Edmund Anthony
2014.030 Barriers to optimising interventions for the prevention and treatment of pneumonia and diarrhoea in Hong Kong children Prof. NELSON Edmund Anthony
2009.154 A Retrospective Study to Assess the Clinical Burden of Community-Acquired Pneumonia (CAP) and Invasive Pneumococcal Disease (IPD) in Hong Kong Professor Nelson Edmund Anthony

Page 168 of 254.